Literature DB >> 1598203

The C terminus of the NF-kappa B p50 precursor and an I kappa B isoform contain transcription activation domains.

P J Morin1, T D Gilmore.   

Abstract

The p50 subunit of the NF-kappa B transcription complex is derived from the N-terminal half of a larger precursor protein, p105. Although a fair amount is known about functions located within the p50 sequences, less is known about the C-terminal half of p105. In this report, we have identified a potent transcription activation domain located in the C terminus of mouse p105. In addition, the I kappa B beta proteins chicken p40 and human MAD-3, proteins that are related to the p105 C terminus, strongly activated transcription in chicken cells and yeast when fused to GAL4 DNA-binding sequences. Furthermore, chicken p40 is primarily located in the nucleus of chicken cells when overexpressed from a retroviral vector. Our results suggest novel models for the function and regulation of NF-kappa B transcription complexes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1598203      PMCID: PMC312378          DOI: 10.1093/nar/20.10.2453

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  39 in total

Review 1.  The inducible transcription activator NF-kappa B: regulation by distinct protein subunits.

Authors:  P A Baeuerle
Journal:  Biochim Biophys Acta       Date:  1991-04-16

2.  The role of SWI4 and SWI6 in the activity of G1 cyclins in yeast.

Authors:  K Nasmyth; L Dirick
Journal:  Cell       Date:  1991-09-06       Impact factor: 41.582

3.  Processing of the precursor of NF-kappa B by the HIV-1 protease during acute infection.

Authors:  Y Rivière; V Blank; P Kourilsky; A Israël
Journal:  Nature       Date:  1991-04-18       Impact factor: 49.962

4.  Generating yeast transcriptional activators containing no yeast protein sequences.

Authors:  D M Ruden; J Ma; Y Li; K Wood; M Ptashne
Journal:  Nature       Date:  1991-03-21       Impact factor: 49.962

5.  Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-kappa B subunit.

Authors:  T Henkel; U Zabel; K van Zee; J M Müller; E Fanning; P A Baeuerle
Journal:  Cell       Date:  1992-03-20       Impact factor: 41.582

6.  Generation of p50 subunit of NF-kappa B by processing of p105 through an ATP-dependent pathway.

Authors:  C M Fan; T Maniatis
Journal:  Nature       Date:  1991-12-05       Impact factor: 49.962

7.  Identification of Ets- and notch-related subunits in GA binding protein.

Authors:  K LaMarco; C C Thompson; B P Byers; E M Walton; S L McKnight
Journal:  Science       Date:  1991-08-16       Impact factor: 47.728

8.  Convergence of Ets- and notch-related structural motifs in a heteromeric DNA binding complex.

Authors:  C C Thompson; T A Brown; S L McKnight
Journal:  Science       Date:  1991-08-16       Impact factor: 47.728

9.  Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity.

Authors:  S Haskill; A A Beg; S M Tompkins; J S Morris; A D Yurochko; A Sampson-Johannes; K Mondal; P Ralph; A S Baldwin
Journal:  Cell       Date:  1991-06-28       Impact factor: 41.582

10.  Cytoplasmic retention, DNA binding and processing of the NF-kappa B p50 precursor are controlled by a small region in its C-terminus.

Authors:  V Blank; P Kourilsky; A Israël
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more
  24 in total

1.  Regulation and function of nuclear IκBα in inflammation and cancer.

Authors:  Ivana Vancurova; Ales Vancura
Journal:  Am J Clin Exp Immunol       Date:  2012-05-25

2.  Loss of IkappaB alpha-mediated control over nuclear import and DNA binding enables oncogenic activation of c-Rel.

Authors:  S Sachdev; M Hannink
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

3.  Interaction of the v-Rel oncoprotein with NF-kappaB and IkappaB proteins: heterodimers of a transformation-defective v-Rel mutant and NF-2 are functional in vitro and in vivo.

Authors:  D W White; G A Pitoc; T D Gilmore
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

4.  Nuclear localization of IkappaB alpha is mediated by the second ankyrin repeat: the IkappaB alpha ankyrin repeats define a novel class of cis-acting nuclear import sequences.

Authors:  S Sachdev; A Hoffmann; M Hannink
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

5.  Bcl-3 expression promotes cell survival following interleukin-4 deprivation and is controlled by AP1 and AP1-like transcription factors.

Authors:  A Rebollo; L Dumoutier; J C Renauld; A Zaballos; V Ayllón; C Martínez-A
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

6.  Ribozyme-mediated targeting of IkappaBgamma inhibits melanoma invasion and metastasis.

Authors:  Sima Z Torabian; David de Semir; Mehdi Nosrati; Sepideh Bagheri; Altaf A Dar; Sylvia Fong; Yong Liu; Scot Federman; Jeff Simko; Chris Haqq; Robert J Debs; Mohammed Kashani-Sabet
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

7.  Alternate RNA splicing of murine nfkb1 generates a nuclear isoform of the p50 precursor NF-kappa B1 that can function as a transactivator of NF-kappa B-regulated transcription.

Authors:  R J Grumont; J Fecondo; S Gerondakis
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

Review 8.  Regulation of serum amyloid A protein expression during the acute-phase response.

Authors:  L E Jensen; A S Whitehead
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

9.  Interaction of the C-terminal region of p105 with the nuclear localisation signal of p50 is required for inhibition of NF-kappa B DNA binding activity.

Authors:  J R Matthews; E Watson; S Buckley; R T Hay
Journal:  Nucleic Acids Res       Date:  1993-09-25       Impact factor: 16.971

10.  Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha.

Authors:  K Brown; S Park; T Kanno; G Franzoso; U Siebenlist
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.